Enlivex Therapeutics Ltd. (ENLV) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Enlivex Therapeutics Ltd.

    NASDAQ: ENLV · Real-Time Price · USD
    1.03
    0.00 (0.00%)
    At close: Sep 26, 2025, 3:56 PM
    1.02
    -0.97%
    Pre-market: Sep 29, 2025, 05:13 AM EDT

    Enlivex Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 3.3M 813K 47.82M 11.2M
    Short-Term Investments
    		 20.2M 26.51M 299K 72.93M
    Long-Term Investments
    		 531K 308K 307K 3K
    Other Long-Term Assets
    		 10K 179K 105K 482K
    Receivables
    		 1.3M n/a n/a 1.09M
    Inventory
    		 n/a n/a 1.18M -12.2M
    Other Current Assets
    		 198K 5.11M n/a 1.2M
    Total Current Assets
    		 25.99M 33.76M 52.33M 86.44M
    Property-Plant & Equipment
    		 1.15M 2.58M 14.9M 8.22M
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 1.69M 3.07M 15.31M 8.7M
    Total Assets
    		 27.69M 36.83M 67.64M 95.15M
    Account Payables
    		 811K 827K 1.95M 878K
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 235K n/a n/a n/a
    Other Current Liabilities
    		 -93K 1.57M n/a n/a
    Total Current Liabilities
    		 3.8M 6.06M 6.61M 4.72M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 n/a n/a n/a n/a
    Total Long-Term Liabilities
    		 299K 686K 4.19M 5.39M
    Total Liabilities
    		 4.1M 6.75M 10.8M 10.11M
    Total Debt
    		 534K 1.03M 4.85M 617K
    Book Value
    		 23.59M 30.08M 56.84M 85.04M
    Book Value Per Share
    		 1.15 1.62 3.09 4.76
    Common Stock
    		 2.69M 2.14M 2.12M 2.11M
    Retained Earnings
    		 -127.11M -112.09M -83.03M -51.97M
    Comprehensive Income
    		 1.1M 1.1M 1.1M 1.1M
    Shareholders Equity
    		 23.59M 30.08M 56.84M 85.04M
    Total Investments
    		 20.73M 26.82M 299K 72.93M

    Add to Watchlist